Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Activities
Net (loss) income	$ (38,357)	$ 13,485
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	80,569	48,931
Equity in net loss from unconsolidated joint ventures	7,412	4,715
Distributions of cumulative earnings from unconsolidated joint ventures	258	188
Equity in net loss on sale of interest in unconsolidated joint venture interest/real estate	79	0
Purchase price and other fair value adjustments	(239)	63
Loss on sale of real estate, net	1,651	1,002
Loan loss and other investment reserves, net of recoveries	6,890	0
Deferred rents receivable	(7,431)	(546)
Non-cash lease expense	5,261	6,043
Other non-cash adjustments	(3,271)	(6,964)
Changes in operating assets and liabilities:
Tenant and other receivables	(969)	13,673
Related party receivables	577	(2,335)
Deferred lease costs	(3,911)	(4,240)
Other assets	(11,160)	(25,076)
Accounts payable, accrued expenses, other liabilities and security deposits	4,656	28,049
Deferred revenue	2,450	3,550
Lease liability - operating leases	(2,116)	864
Net cash provided by operating activities	42,349	81,402
Investing Activities
Additions to land, buildings and improvements	(61,918)	(61,680)
Acquisition deposits and deferred purchase price	0	(15,000)
Investments in unconsolidated joint ventures	(22,985)	(11,399)
Distributions in excess of cumulative earnings from unconsolidated joint ventures	41,812	16,089
Net proceeds from disposition of real estate/joint venture interest	0	91,994
Other investments	(17,700)	209
Origination of debt and preferred equity investments	(5,578)	(13,122)
Repayments or redemption of debt and preferred equity investments	0	6,405
Net cash (used in) provided by investing activities	(66,369)	13,496
Financing Activities
Proceeds from mortgages and other loans payable	0	5,309
Repayments of mortgages and other loans payable	(1,473)	(55,715)
Proceeds from revolving credit facility and unsecured notes	143,000	320,000
Repayments of revolving credit facility and unsecured notes	(78,000)	(210,000)
Proceeds from stock options exercised and DRSPP issuance	184	89
Repurchase of common stock	0	(151,197)
Redemption of preferred stock	0	(17,967)
Redemption of OP units	(5,220)	(18,272)
Distributions to noncontrolling interests in other partnerships	(136)	(123)
Contributions from noncontrolling interests in other partnerships	426	0
Distributions to noncontrolling interests in the Operating Partnership	(3,822)	(4,415)
Dividends paid on common and preferred stock	(57,373)	(66,339)
Other obligations related to secured borrowing	0	77,874
Tax withholdings related to restricted share awards	0	(3,888)
Deferred loan costs	(358)	80
Net cash used in financing activities	(2,772)	(124,564)
Net decrease in cash, cash equivalents, and restricted cash	(26,792)	(29,666)
Cash, cash equivalents, and restricted cash at beginning of year	384,054	336,984
Cash, cash equivalents, and restricted cash at end of period	357,262	307,318
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Issuance of special dividend paid primarily in stock	0	160,620
Tenant improvements and capital expenditures payable	0	8,700
Fair value adjustment to noncontrolling interest in the Operating Partnership	10,147	43,023
Contribution to consolidated joint venture interest	8,134	0
Removal of fully depreciated commercial real estate properties	4,247	651
Cash and cash equivalents	158,937	223,674
Restricted cash	198,325	83,644
Total cash, cash equivalents, and restricted cash	$ 357,262	$ 307,318